BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Varannes SBD, Sacher-Huvelin S, Vavasseur F, Masliah C, Rhun ML, Aygalenq P, Bonnot-Marlier S, Lequeux Y, Galmiche JP. Rabeprazole test for the diagnosis of gastro-oesophageal reflux disease: Results of a study in a primary care setting. World J Gastroenterol 2006; 12(16): 2569-2573 [PMID: 16688803 DOI: 10.3748/wjg.v12.i16.2569] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Smout AJPM. Review article: the measurement of non-acid gastro-oesophageal reflux: REVIEW: NON-ACID REFLUX. Alimentary Pharmacology & Therapeutics 2007;26:7-12. [DOI: 10.1111/j.1365-2036.2007.03527.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
2 Tseng P, Lee Y, Chiu H, Wang H, Lin J, Wu M. A Comparative Study of Proton-pump Inhibitor Tests for Chinese Reflux Patients in Relation to the CYP2C19 Genotypes. Journal of Clinical Gastroenterology 2009;43:920-5. [DOI: 10.1097/mcg.0b013e3181960628] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 de Leone A, Tonini M, Dominici P, Grossi E, Pace F; EMERGE Study Group. The proton pump inhibitor test for gastroesophageal reflux disease: optimal cut-off value and duration. Dig Liver Dis 2010;42:785-90. [PMID: 20452300 DOI: 10.1016/j.dld.2010.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
4 Bytzer P, Jones R, Vakil N, Junghard O, Lind T, Wernersson B, Dent J. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2012;10:1360-1366. [PMID: 22813439 DOI: 10.1016/j.cgh.2012.06.030] [Cited by in Crossref: 72] [Cited by in F6Publishing: 46] [Article Influence: 7.2] [Reference Citation Analysis]
5 Talley NJ, Ruff K, Jiang X, Jung HK. The Rome III Classification of Dyspepsia: Will It Help Research? Dig Dis 2008;26:203-9. [DOI: 10.1159/000121347] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
6 Aanen MC, Weusten BL, Numans ME, de Wit NJ, Baron A, Smout AJ. Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther. 2006;24:1377-1384. [PMID: 17059519 DOI: 10.1111/j.1365-2036.2006.03121.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
7 Moraes-filho JPP, Navarro-rodriguez T, Barbuti R, Eisig J, Chinzon D, Bernardo W. Guidelines for the diagnosis and management of gastroesophageal reflux disease: an evidence-based consensus. Arq Gastroenterol 2010;47:99-115. [DOI: 10.1590/s0004-28032010000100017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
8 Zhang M, Pandolfino JE, Zhou X, Tan N, Li Y, Chen M, Xiao Y. Assessing different diagnostic tests for gastroesophageal reflux disease: a systematic review and network meta-analysis. Therap Adv Gastroenterol 2019;12:1756284819890537. [PMID: 31803253 DOI: 10.1177/1756284819890537] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
9 Gasiorowska A, Fass R. The proton pump inhibitor (PPI) test in GERD: does it still have a role? J Clin Gastroenterol 2008;42:867-74. [PMID: 18645525 DOI: 10.1097/MCG.0b013e31816c47ed] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
10 Lee BS, Lee SH, Jang DK, Chung KH, Hwang JH, Jang SE, Cha BH, Ryu JK, Kim YT. Belching during gastroscopy and its association with gastroesophageal reflux disease. Dis Esophagus 2016;29:342-9. [PMID: 25708811 DOI: 10.1111/dote.12326] [Reference Citation Analysis]
11 Reimer C, Bytzer P. Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse. Eur J Gastroenterol Hepatol. 2010;22:1182-1188. [PMID: 20664352 DOI: 10.1097/meg.0b013e32833d56d1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
12 Pace F, Pace M. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease. Expert Rev Gastroenterol Hepatol 2010;4:423-7. [PMID: 20678016 DOI: 10.1586/egh.10.38] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
13 Lee SH, Jang BI, Jeon SW, Kwon JG, Kim EY, Cho KB, Park CG, Yang CH; Daegu-Gyeongbuk Gastrointestinal Study Group. A multicenter, randomized, comparative study to determine the appropriate dose of lansoprazole for use in the diagnostic test for gastroesophageal reflux disease. Gut Liver 2011;5:302-7. [PMID: 21927658 DOI: 10.5009/gnl.2011.5.3.302] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]